Bleomycinic acid and process for preparing thereof
    1.
    再颁专利
    Bleomycinic acid and process for preparing thereof 失效
    博来霉素酸及其制备方法

    公开(公告)号:USRE30413E

    公开(公告)日:1980-10-07

    申请号:US41995

    申请日:1979-05-24

    IPC分类号: C07K9/00

    摘要: A process for preparing bleomycinic acid having a melting point of 228.degree.-230.degree. C. (decomposition) and an analysis of C: 40.80%, H: 5.29%, N: 16.45%, O: 24.78%, S: 4.53%, Cl: 3.37%, and Cu: 4.78% which is characterized by being soluble in water, difficultly soluble in methanol, acetic acid and dimethylsulfoxide, and insoluble in ethanol, ethyl acetate, acetone and ether, and which tests positive to Pauly and Ehrlich reactions but tests negative to ninhydrin, Sakaguchi, Dragendorf, Tollens, ferric chloride, Fehling and Molish reactions, and which has a maximum ultraviolet absorption spectrum at 246 m.mu. and 292 m.mu. and which has an infrared absorption spectrum bands at 3350, 1720, 1670, 1640, 1580, 1460, 1365, 1050, 770 (cm.sup.-1), and which can be hydrolyzed to yield 2'-(2-aminoethyl)-2,4'-bithiazole-4-carboxylic acid, L-threonine, 4-amino-3-hydroxy-2-methyl-.eta.-valeric acid, .beta.-hydroxy-histidine, .beta.-amino-.beta.-(4-amino-6-carboxy-5-methylpyrimidine-2-yl)-propionic acid, L-.beta.-amino-alanine, L-gulose and 3-O-carbamoyl-D-mannose, which comprises hydrolyzing bleomycin in the presence of a mycelium mass or enzyme.

    Bleomycinic acid and process for preparing thereof
    2.
    发明授权
    Bleomycinic acid and process for preparing thereof 失效
    博来霉素酸及其制备方法

    公开(公告)号:US3932374A

    公开(公告)日:1976-01-13

    申请号:US479087

    申请日:1974-06-13

    CPC分类号: C07H15/26

    摘要: A process for preparing bleomycinic acid having a melting point of 228.degree.-230.degree.C. (decomposition) and an analysis of C : 40.80%, H : 5.29%, N : 16.45%, O : 24.78%, S : 4.53%, Cl : 3.37%, and Cu : 4.78% which is characterized by being soluble in water, difficultly soluble in methanol, acetic acid and dimethylsulfoxide, and insoluble in ethanol, ethyl acetate, acetone and ether, and which tests positive to Pauly and Ehrlich reactions but tests negative to ninhydrin, Sakaguchi, Dragendorf, Tollens, ferric chloride, Fehling and Molish reactions, and which has a maximum ultraviolet absorption spectrum at 246 m.mu. and 292 m.mu. and which has an infrared absorption spectrum bands at 3350, 1720, 1670, 1640, 1580, 1460, 1365, 1050, 770 (cm.sup.-.sup.1), and which can be hydrolyzed to yield 2'-(2-aminoethyl)-2,4'-bithiazole-4-carboxylic acid, L-threonine, 4-amino-3-hydroxy-2-methyl-.eta.-valeric acid, .beta.-hydroxy-histidine, .beta.-amino-.beta.-(4-amino-6-carboxy-5-methylpyrimidine-2-yl)-propionic acid, L-.beta.-amino-alanine, L-gulose and 3-0-carbamoyl-D-mannose, which comprises hydrolyzing bleomycin in the presence of a mycelium mass or enzyme.

    摘要翻译: 制备熔点为228〜-230℃的博来霉素酸(分解),C:40.80%,H:5.29%,N:16.45%,O:24.78%,S:4.53%的分析方法, Cl:3.37%,Cu:4.78%,其特征在于可溶于水,难溶于甲醇,乙酸和二甲基亚砜,不溶于乙醇,乙酸乙酯,丙酮和乙醚,并对Pauly和Ehrlich反应进行检测 但对茚三酮,Sakaguchi,Dragendorf,Tollens,氯化铁,Fehling和Molish反应阴性测试,其最大紫外吸收光谱为246μm和292μm,红外吸收光谱带为3350,1720,1670 ,1640,1580,1460,1365,1050,770(cm -1),并可水解得到2' - (2-氨基乙基)-2,4'-联噻唑-4-羧酸,L- 苏氨酸,4-氨基-3-羟基-2-甲基 - 戊酸,β-羟基 - 组氨酸,β-氨基-β-(4-氨基-6-羧基-5-甲基嘧啶-2-基) - 丙酸 一个 cid,L-β-氨基 - 丙氨酸,L-古洛糖和3-0-氨基甲酰-D-甘露糖,其包括在菌丝体或酶存在下水解博来霉素。

    Cyclic guanidine derivatives, anti-ulceratives and method of
manufacturing the same
    8.
    发明授权
    Cyclic guanidine derivatives, anti-ulceratives and method of manufacturing the same 失效
    环状胍衍生物,抗溃疡及其制造方法

    公开(公告)号:US5240944A

    公开(公告)日:1993-08-31

    申请号:US665662

    申请日:1991-03-07

    CPC分类号: C07D471/14 C07D487/04

    摘要: Derivatives of cyclic guanidine are disclosed, which are represented by the following formula:A--S--Rwherein A is ##STR1## R.sub.1 represent a lower alkyl or substituted phenyl or unsubstituted phenyl group; R.sub.2 is a lower alkyl; R.sub.3 is H or a lower alkyl; R is lower alkyl, alkenyl, alkynyl, alkanoyl, alkenoyl, dialkylaminoalkyl, cyanoalkyl, alkoxycarbonylalkyl, carboxylalkenyl, alkoxycarbonyl, alkoxyalkylcarbonyl, dialkylaminocarbonyl, dialkylaminothiocarbonyl, phenoxyalkylcarbonyl, piperidinoalkyl, pyridine carbonyl, substituted or unsubstituted benzoyl, or substituted or unsubstituted benzyl group. The compounds of the present invention are useful as anti-ulcerative agents.

    摘要翻译: 公开了由下式表示的环状胍的衍生物:A-S-R其中A为低级烷基或取代的苯基或未取代的苯基; R2是低级烷基; R3是H或低级烷基; R是低级烷基,烯基,炔基,烷酰基,烯酰基,二烷基氨基烷基,氰基烷基,烷氧基羰基烷基,羧基烯基,烷氧基羰基,烷氧基烷基羰基,二烷基氨基羰基,二烷基氨基硫代羰基,苯氧基烷基羰基,哌啶子基烷基,吡啶羰基,取代或未取代的苯甲酰基或取代或未取代的苄基。 本发明的化合物可用作抗溃疡剂。

    Cyclic guanidine derivatives, anti-ulceratives and methods of
manufacturing the same
    9.
    发明授权
    Cyclic guanidine derivatives, anti-ulceratives and methods of manufacturing the same 失效
    环状胍衍生物,抗溃疡及其制造方法

    公开(公告)号:US5008282A

    公开(公告)日:1991-04-16

    申请号:US450264

    申请日:1989-12-13

    CPC分类号: C07D471/14 C07D487/04

    摘要: Derivatives of cyclic guanidine are disclosed, which are represented by the following formula:A--S--Rwherein A is ##STR1## R.sub.1 represent a lower alkyl or substituted phenyl or unsubstituted phenyl group; R.sub.2 is a lower alkyl; R.sub.3 is H or a lower alkyl; R is lower alkyl, alkenyl, alkynyl, alkanoyl, alkenoyl, dialkylaminoalkyl, cyanoalkyl, alkoxycarbonylalkyl, carboxylalkenyl, alkoxycarbonyl, alkoxyalkylcarbonyl, dialkylaminocarbonyl, dialkylaminothiocarbonyl, phenoxyalkylcarbonyl, piperidinoalkyl, pyridine carbonyl, substituted or unsubstituted benzoyl, or substituted or unsubstituted benzyl group.The compounds of the present invention are useful as anti-ulcerative agents.

    摘要翻译: 公开了由下式表示的环状胍的衍生物:A-S-R,其中A为低级烷基或取代的苯基或未取代的苯基; R2是低级烷基; R3是H或低级烷基; R是低级烷基,烯基,炔基,烷酰基,烯酰基,二烷基氨基烷基,氰基烷基,烷氧基羰基烷基,羧基烯基,烷氧基羰基,烷氧基烷基羰基,二烷基氨基羰基,二烷基氨基硫代羰基,苯氧基烷基羰基,哌啶子基烷基,吡啶羰基,取代或未取代的苯甲酰基或取代或未取代的苄基。 本发明的化合物可用作抗溃疡剂。